21 May 2009
Transendoscopic islet transplantation to gastric submucosa (eGSM-ITX) of pigs with streptozotocine induced diabetes – preliminary results
M Wszola, A Berman, M Fabisiak, R Kieszek, M Zmudzka, P Domagala, A Perkowska-Ptasinska, K Pawelec, M Sabat, L Kownacki, K Ostrowski, L Gorski, A Wernikowski, W Klucinski, O Rowinski, L Paczek, A Kwiatkowski, A ChmuraAnn Transplant 2009; 14(1): 46-46 :: ID: 880368
Abstract
Background: Islets and pancreas transplantation have become standard treatments of patients with diabetic complications. However pancreas transplantation is associated with high incidence of complications and the long-term results of islet transplantation are still unsatisfactory. Loss of pancreatic islets grafts is not only caused by immunological reactions but also due to the site of grafting and IBMIR. Gastric submucosa might be an alternative site for transplantation. The aim of this study was to assess the possibility of endoscopic islets transplantation into the gastric submucosa.
Material/Methods: 20 Landrace pigs weighing 19-24 kg were obtained for the study.7 animals were controls(C-group)and 13 were Transplantation group(TX group). In both groups diabetes was induced by streptozotocine (stz) infusion at 200 mg/kg. At 7 days post stz infusion pigs of both groups underwent endoscopy-in group-C to assess the feasibility of gastroscopic examination under general anesthesia in pigs with diabetes and in Tx-group to perform eGSM-ITx. Immunosuppression consisted of tacrolimus,sirolimus. At 7 days post transplantation, control gastroscopy was performed to assess the gastric mucosa and to take biopsies for histopathology. 10 to 30 days after eGSM-ITx Magnetic Resonance(MRI) examination was performed and pigs were euthanized. Stomach and pancreas were obtained at autopsy for histopathology. For 10 days after diabetes induction (up to three days after eGSM-ITx)in both groups, insulin was given to reach glycemia between 150-200 mg/dl,after that period insulin was given only when glycemia exceeded 600 mg/dl.
Results: There were no differences in insulin requirement and glycemia up to the day of eGSM-ITx between the groups. Tx-group animals received a mean of 6000 IEQ/kg. Tx-group animals had a significantly lower insulin requirement and significantly lower mean glycemia since the first day post transplantation. This trend was observed till the end of study at 1 month. Beginning at day 4 post eGSM-ITx pigs from the ITx-group did not receive insulin. There were no signs of perforation, ulceration or bleeding after the eGSM-ITx on gastroscopy and histopathological examination. In MRI scans unspecific thickening of gastric wall was observed at sites of islet deposition.
Conclusions: Transendoscopic islets transplantation into gastric submucosa is feasible and a safe procedure in an experimental animal setting. Its potential for clinical application in human subjects needs further studies.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






